Skip to main content
SpringerLink
Log in

Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes

  • Editorial
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Becker A, Albrecht C, Knaapen AM, Schins RP, Höhr D, Ledermann K, Borm PJ (2006) Induction of CYP1A1 in rat lung cells following in vivo and in vitro exposure to quartz. Arch Toxicol 80:258–268

    Article  PubMed  CAS  Google Scholar 

  • Bernshausen T, Jux B, Esser C, Abel J, Fritsche E (2006) Tissue distribution and function of the Aryl hydrocarbon receptor repressor (AhRR) in C57BL/6 and Aryl hydrocarbon receptor deficient mice. Arch Toxicol 80:206–211

    Article  PubMed  CAS  Google Scholar 

  • Brulport M, Schormann W, Bauer A, Hermes M, Elsner C, Hammersen FJ, Beerheide W, Spitkovsky D, Härtig W, Nussler A, Horn LC, Edelmann J, Pelz-Ackermann O, Petersen J, Kamprad M, von Mach M, Lupp A, Zulewski H, Hengstler JG (2007) Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. Hepatology 46:861–870

    Article  PubMed  Google Scholar 

  • Carmo H, Brulport M, Hermes M, Oesch F, de Boer D, Remião F, Carvalho F, Schön MR, Krebsfaenger N, Doehmer J, Bastos Mde L, Hengstler JG (2007) CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA). Toxicology 229:236–244

    Article  PubMed  CAS  Google Scholar 

  • Carmo H, Brulport M, Hermes M, Oesch F, Silva R, Ferreira LM, Branco PS, Boer D, Remião F, Carvalho F, Schön MR, Krebsfaenger N, Doehmer J, Bastos Mde L, Hengstler JG (2006) Influence of CYP2D6 polymorphism on 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity. Pharmacogenet Genomics 16:789–799

    Article  PubMed  CAS  Google Scholar 

  • Dávila-Borja VM, Belmont JA, Espinosa JJ, Moreno-Sánchez R, Albores A, Montero RD (2007) Induction of CYP1A1 and CYP2E1 in rat liver by histamine: binding and kinetic studies. Arch Toxicol 81:697–709

    Article  PubMed  CAS  Google Scholar 

  • Dörrenhaus A, Müller T, Roos PH (2007) Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers. Arch Toxicol 81:19–25

    Article  PubMed  CAS  Google Scholar 

  • Gebhardt R, Hengstler JG, Müller D, Glöckner R, Buenning P, Laube B, Schmelzer E, Ullrich M, Utesch D, Hewitt N, Ringel M, Hilz BR, Bader A, Langsch A, Koose T, Burger HJ, Maas J, Oesch F (2003) New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 35:145–213

    Article  PubMed  CAS  Google Scholar 

  • Guéguen Y, Souidi M, Baudelin C, Dudoignon N, Grison S, Dublineau I, Marquette C, Voisin P, Gourmelon P, Aigueperse J (2006) Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. Arch Toxicol 80:187–195

    Article  PubMed  CAS  Google Scholar 

  • Hengstler JG, Arand M, Herrero ME, Oesch F (1998) Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154:47–85

    Google Scholar 

  • Hengstler JG, Brulport M, Schormann W, Bauer A, Hermes M, Nussler AK, Fandrich F, Ruhnke M, Ungefroren H, Griffin L, Bockamp E, Oesch F, von Mach MA (2005) Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 1:61–74

    Article  PubMed  CAS  Google Scholar 

  • Hengstler JG, Utesch D, Steinberg P, Platt KL, Diener B, Ringel M, Swales N, Fischer T, Biefang K, Gerl M, Böttger T, Oesch F (2000) Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81–118

    Article  PubMed  CAS  Google Scholar 

  • Hermansson V, Asp V, Bergman A, Bergström U, Brandt I (2007) Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o, p’-DDD in Y–1 adrenal cells. Arch Toxicol 81:793–801

    Article  PubMed  CAS  Google Scholar 

  • Hewitt NJ, Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse E, Groothuis GM, Hengstler JG (2007) Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234

    Article  PubMed  CAS  Google Scholar 

  • Höhme S, Hengstler JG, Brulport M, Schäfer M, Bauer A, Gebhart R, Drasdo D (2007) Mathematical modelling of liver regeneration after intoxication with CC1(4). Chem Biol Interact 168:74–93

    Article  PubMed  CAS  Google Scholar 

  • Ito Y, Yamanoshita O, Kurata Y, Kamijima M, Aoyama T, Nakajima T (2007) Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets. Arch Toxicol 81:219–226

    Article  PubMed  CAS  Google Scholar 

  • Kafert-Kasting S, Alexandrova K, Barthold M, Laube B, Friedrich G, Arseniev L, Hengstler JG (2006) Enzyme induction in cryopreserved human hepatocyte cultures. Toxicology 220:117–125

    Article  PubMed  CAS  Google Scholar 

  • Kamimura H (2006) Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations. Arch Toxicol 80:732–738

    Article  PubMed  CAS  Google Scholar 

  • Klingmüller U, Bauer A, Bohl S, Nickel PJ, Breitkopf K, Dooley S, Zellmer S, Kern C, Merfort I, Sparna T, Donauer J, Walz G, Geyer M, Kreutz C, Hermes M, Götschel F, Hecht A, Walter D, Egger L, Neubert K, Borner C, Brulport M, Schormann W, Sauer C, Baumann F, Preiss R, MacNelly S, Godoy P, Wiercinska E, Ciuclan L, Edelmann J, Zeilinger K, Heinrich M, Zanger UM, Gebhardt R, Maiwald T, Heinrich R, Timmer J, von Weizsäcker F, Hengstler JG (2006) Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) 153:433–447

    Google Scholar 

  • Kurebayashi H, Ohno Y (2006) Metabolism of acrylamide to glycidamide and their cytotoxicity in isolated rat hepatocytes: protective effects of GSH precursors. Arch Toxicol 80:820–828

    Article  PubMed  CAS  Google Scholar 

  • Masubuchi Y, Kawasaki M, Horie T (2006) Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats. Arch Toxicol 80:347–353

    Article  PubMed  CAS  Google Scholar 

  • Mitchell AE, Burns SA, Rudolf JL (2007) Isozyme- and gender-specific induction of glutathione S-transferases by flavonoids. Arch Toxicol 81:777–784

    Article  PubMed  CAS  Google Scholar 

  • Moustafa GG, Ibrahim ZS, Hashimoto Y, Alkelch AM, Sakamoto KQ, Ishizuka M, Fujita S (2007) Testicular toxicity of profenofos in matured male rats. Arch Toxicol 81:75–81

    Article  CAS  Google Scholar 

  • Nannelli A, Messina A, Marini S, Trasciatti S, Longo V, Gervasi PG (2007) Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues. Arch Toxicol 81:479–487

    Article  PubMed  CAS  Google Scholar 

  • Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H (2008) Inhibition and induction of human cytochrome P450 enzymes—current status. Arch Toxicol (this issue)

  • Roos PH, Belik R, Föllmann W, Degen GH, Knopf HJ, Bolt HM, Golka K (2006) Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments. Arch Toxicol 80:45–52

    Article  PubMed  CAS  Google Scholar 

  • Saussele T, Burk O, Blievernicht JK, Klein K, Nussler A, Nussler N, Hengstler JG, Eichelbaum M, Schwab M, Zanger UM (2007) Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole. Clin Pharmacol Ther 82:265–274

    Article  PubMed  CAS  Google Scholar 

  • Skupinska K, Misiewicz I, Kasprzycka-Guttman T (2007) A comparison of the concentration-effect relationships of PAHs on CYP1A induction in HepG2 and Mcf7 cells. Arch Toxicol 81:183–200

    Article  PubMed  CAS  Google Scholar 

  • Souma S, Sekimoto M, Degawa M (2006) Species difference in the induction of hepatic CYP1A subfamily enzymes, especially CYP1A2, by 2-methoxy–4-nitroaniline among rats, mice, and guinea pigs. Arch Toxicol 80:739–747

    Article  PubMed  CAS  Google Scholar 

  • Ulusoy G, Arinç E, Adali O (2007) Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol 81:711–718

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leibniz Research Centre for Working Environment and Human Factors (IfADo), Institut für Arbeitsphysiologie an der Universität Dortmund, Ardeystrasse 67, 44139, Dortmund, Germany

    J. G. Hengstler & H. M. Bolt

Authors
  1. J. G. Hengstler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Bolt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. G. Hengstler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hengstler, J.G., Bolt, H.M. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes. Arch Toxicol 82, 665–666 (2008). https://doi.org/10.1007/s00204-008-0355-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-008-0355-1

Search

Navigation